Trials / Completed
CompletedNCT00916474
Virology Follow up Study in Subjects Previously Treated With Telaprevir
EXTEND: A 3-Year, Virology Follow up Study in Subjects Previously Treated With Telaprevir in Select Clinical Studies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 408 (actual)
- Sponsor
- Vertex Pharmaceuticals Incorporated · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Observational follow-up study to assess long-term response to telaprevir and to evaluate changes in Hepatitis C virus over time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | telaprevir |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2009-06-09
- Last updated
- 2014-02-27
Locations
41 sites across 5 countries: United States, Canada, France, Germany, Puerto Rico
Source: ClinicalTrials.gov record NCT00916474. Inclusion in this directory is not an endorsement.